Skip to Content

EHA23 – Novel CAR Therapy for AML Shows Favorable Pre-Clinical Outcomes

A novel combinatorial CAR therapy ADCLEC.syn1, designed to co-target ADGRE2 and CLEC12A for selective elimination of AML, shows exciting results.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top